Expressiona and Diagnostic Potential of miRNAs in NSCLC
The Expression Profiling of Serum miRNAs (106b-5p, 601, and 760) in Non-small Cell Lung Cancer Patients
1 other identifier
observational
100
1 country
1
Brief Summary
Its to explore the expression pattern, diagnostic and prognostic potentials of miRs (106b-5p, 601 and 760) in serum of NSCLC patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2022
CompletedFirst Submitted
Initial submission to the registry
April 4, 2023
CompletedFirst Posted
Study publicly available on registry
April 18, 2023
CompletedApril 18, 2023
April 1, 2023
4.1 years
April 4, 2023
April 4, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Determination of the expression
Expression profiling of the selected miRNAs
By the end of the study (September 2022)
Study Arms (2)
NSCLC patients
Patients were diagnosed with NSCLC at any stage, then will be subdivided into Early stage, Lympho-node involvement stage and Distant metastatic stage
Control subjects
Appearantly healthy age-matched individuals
Interventions
Eligibility Criteria
Case-control
You may qualify if:
- First time and recently diagnosed NSCLC patient
You may not qualify if:
- Recurrent NSCLC
- Start of chemotherapy, radiotherapy or surgical intervention
- Previous treatment
- Cancer history
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt
Cairo, 11231, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor Associate of Medical Biochemistry and Molecular Biology
Study Record Dates
First Submitted
April 4, 2023
First Posted
April 18, 2023
Study Start
September 1, 2018
Primary Completion
September 30, 2022
Study Completion
September 30, 2022
Last Updated
April 18, 2023
Record last verified: 2023-04